DefiniGEN: DefiniGEN secures 3.25 million in funding led by BGF

DefiniGEN - a provider of human cell products and services - has closed a £3.25 million funding round to accelerate its next phase of growth. This includes £2 million from BGF, the UK's most active investor, alongside its existing consortium [...]The post DefiniGEN secures £3.25 million in funding led by BGF appeared first on UK Business Angels Association.